ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,476Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 1185

$1.08M Total Retail Price of All Prescriptions

Rank: 30 out of 1185

848 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 848 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 848 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 18,790 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
PRAVASTATIN SODIUM 1,042 746 1 7
AMLODIPINE BESYLATE 920 760 2 1
OMEPRAZOLE 871 632 3 6
LISINOPRIL 786 543 4 4
SIMVASTATIN 785 558 5 5
WARFARIN SODIUM 764 584 6 21
TRAMADOL HCL 676 367 7 16
LEVOTHYROXINE SODIUM 671 515 8 3
METOPROLOL TARTRATE 571 441 9 10
FUROSEMIDE 545 418 10 8
HYDROCODONE-ACETAMINOPHEN 450 342 S3 11 2
ZOLPIDEM TARTRATE 391 265 12 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 382 295 13 14
METFORMIN HCL ER 373 254 14 35
POTASSIUM CHLORIDE 369 327 15 18
LOSARTAN-HYDROCHLOROTHIAZIDE 366 317 16 36
LOSARTAN POTASSIUM 328 287 17 26
HYDROCHLOROTHIAZIDE 327 248 18 12
CARVEDILOL 315 258 19 24
TAMSULOSIN HCL 312 227 20 34
GABAPENTIN 308 222 21 13
ATORVASTATIN CALCIUM 304 218 22 11
GLIMEPIRIDE 295 213 23 49
METFORMIN HCL 279 188 24 9
RANITIDINE HCL 255 175 25 17
CITALOPRAM HBR 239 151 26 22
ALENDRONATE SODIUM 234 215 27 40
SPIRONOLACTONE 214 172 28 75
SERTRALINE HCL 201 129 29 25
ATENOLOL 188 172 30 28
NAMENDA 182 182 31 43
CLOPIDOGREL 181 141 32 31
PREDNISONE 181 161 32 33
ALLOPURINOL 173 124 34 30
DONEPEZIL HCL 154 154 35 32
FLUOXETINE HCL 149 87 36 52
KLOR-CON M10 135 111 37 141
MELOXICAM 135 103 37 27
SPIRONOLACTONE-HCTZ 131 108 39 221
LANTUS 128 55 40 66
FELODIPINE ER 125 81 41 206
TRIAMTERENE-HCTZ 125 110 41 71
DIOVAN 124 106 43 37
PROMETHAZINE HCL 123 42 R 44 76
METOPROLOL SUCCINATE 123 91 44 20
FINASTERIDE 122 119 46 132
DIOVAN HCT 122 85 46 46
PLAVIX 121 90 48 45
CRESTOR 119 100 49 23
SULFAMETHOXAZOLE-TRIMETHOPRIM 117 98 50 91
FLUTICASONE PROPIONATE 116 100 51 29
ACTOS 113 73 52 86
INSULIN SYRINGE 107 73 53 90
CLONIDINE HCL 107 73 53 47
HYDROXYCHLOROQUINE SULFATE 104 62 55 275
DIGOXIN 103 91 56 67
NEXIUM 102 61 57 19
OLANZAPINE 101 85 58 156
GLIPIZIDE 100 85 59 56
CEPHALEXIN 100 91 59 103
FLUCONAZOLE 100 63 59 147
AMITRIPTYLINE HCL 97 53 R 62 51
DILTIAZEM 24HR ER 96 83 63 143
LOVASTATIN 94 78 64 63
CYCLOBENZAPRINE HCL 92 36 R 65 53
SYMBICORT 92 52 65 144
OXYBUTYNIN CHLORIDE ER 88 67 67 173
MIRTAZAPINE 88 76 67 57
DICLOFENAC SODIUM 86 81 69 81
POLYETHYLENE GLYCOL 3350 86 59 69 60
ADVAIR DISKUS 86 61 69 54
AMLODIPINE BESYLATE-BENAZEPRIL 83 52 72 42
ISOSORBIDE MONONITRATE ER 80 72 73 48
NOVOLIN R 80 50 73 245
AMOXICILLIN 79 62 75 99
METOCLOPRAMIDE HCL 79 51 75 134
PHENYTOIN SODIUM EXTENDED 79 54 75 111
FENOFIBRATE 78 50 78 55
SEROQUEL XR 76 13 79 251
PROAIR HFA 74 40 80 50
DOXAZOSIN MESYLATE 74 74 80 84
PIOGLITAZONE HCL 73 44 R 82 243
KLOR-CON 10 71 44 83 118
GLIPIZIDE ER 71 58 83 77
DILTIAZEM 24HR CD 69 69 85 123
HUMULIN 70-30 68 59 86 231
ATENOLOL-CHLORTHALIDONE 68 54 86 122
FENTANYL 67 67 S2 88 107
NAPROXEN 67 37 88 92
TRAZODONE HCL 67 42 88 38
LABETALOL HCL 67 33 88 198
SULINDAC 65 26 92 234
TORSEMIDE 65 50 92 145
GLYBURIDE-METFORMIN HCL 64 26 R 94 88
CARBIDOPA-LEVODOPA 64 49 94 142
QUETIAPINE FUMARATE 63 50 96 93
ZETIA 63 19 96 78
DILTIAZEM ER 60 37 98 153
ESCITALOPRAM OXALATE 60 36 98 79
VENTOLIN HFA 60 40 98 83
SPIRIVA 60 45 98 64
ROPINIROLE HCL 60 43 98 108
DOXYCYCLINE HYCLATE 59 48 103 116
DIVALPROEX SODIUM 59 59 103 96
BUMETANIDE 59 59 103 190
CYMBALTA 59 38 103 44
PREMARIN 59 48 R 103 152
AZITHROMYCIN 58 39 108 39
NADOLOL 58 42 108 261
LANTUS SOLOSTAR 56 24 110 104
KLOR-CON M20 56 45 110 59
SYNTHROID 55 55 112 61
EXFORGE 53 39 113 161
PAROXETINE HCL 53 37 113 73
SINGULAIR 51 27 115 106
GLIPIZIDE XL 51 38 115 95
PROPRANOLOL HCL 50 49 117 163
PANTOPRAZOLE SODIUM 50 42 117 58
NOVOLOG 50 36 117 127
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.